Preparing for future pandemics
CEPI is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
Find out more![healthworker in full PPE looking back at the camera](https://static.cepi.net/images/3840x2160/2024-03/Healthworker-in-PPE-COVID-19-testing-in-Madagascar_blue-filter.webp)
We want to create a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.
Our approach![Our approach image](https://static.cepi.net/images/3840x2160/2024-01/homepage-our-approach.webp)
![A microscopic image of human cells](https://static.cepi.net/images/1024x600/2023-12/Close-up-image-of-cells_1440x810_blue-filter.webp)
Calls for Proposals
Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
![Vaccine vials on a conveyor belt in a manufacturing laboratory](https://static.cepi.net/images/1024x600/2023-12/Vaccine-production-line_1440x810_blue-filter.webp)
CEPI 2.0 and the 100 Days Mission
CEPI’s 2022-2026 strategy, known as CEPI 2.0, will help Prepare, Transform, and Connect the world so that it can respond to the next Disease X threat with a new vaccine in just three months.
![historic image of red cross workers putting flu victim into cart](https://static.cepi.net/images/1024x600/2024-06/Orthomyxovirus-cover-image_1440x810_blue-filter.webp)
The Orthomyxoviruses
These viral culprits have caused the deadliest pandemics in human history
![Campaign logo for the The Viral Most Wanted series on blue background with red particles](https://static.cepi.net/images/1024x600/2023-12/Viral-most-wanted-logo-on-card_1440x810.webp)
The Viral Most Wanted
Join CEPI’s disease detectives as they investigate the viral families that have threatened human life for centuries.
$12.5 trillion
IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024
50+
Number of CEPI-supported vaccine candidates or platform technologies.
$2.8 billion
The minimum average cost to progress one vaccine each against 11 WHO priority infectious diseases
Emerging infectious diseases affect us all. They do not respect borders.
A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.
We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.
![A group of health leaders with face covering holding up up signs containing the logo for COVAX, CEPI, GAVI, Unicef, Organisation mondiale de la Sante and ACT accelerator](https://static.cepi.net/images/3840x2160/2023-12/Health-leaders-with-COVAX-signs_creditUnicef_1440x810.webp)